Pancreatic Cancer Research

ResearcherLanzhou UniversityActive in the last 2 years

Xiaolong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5899-6563; OpenAlex author ID A5053748954. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactylation. Co-author DOI 10.1186/s12885-025-15172-y↗
  2. Pan‑cancer analysis identified ARHGAP23 as a potential biomarker for pancreatic adenocarcinoma. Co-author DOI 10.3892/mco.2023.2696↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Gao · 1 shared paper, 2025 · strength 0.26
  2. Hao Chen · 1 shared paper, 2025 · strength 0.26
  3. Zhen Ma · 1 shared paper, 2025 · strength 0.26
  4. Bin Ma · 1 shared paper, 2025 · strength 0.26
  5. Pengxian Tao · 1 shared paper, 2023 · strength 0.20
  6. Xin Li · 1 shared paper, 2023 · strength 0.20
  7. Yulan Li · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.